Research progress on immune checkpoint inhibitors in intrahepatic cholangiocarcinoma
Background Intrahepatic cholangiocarcinoma (ICC) is a relatively uncommon but lethal neoplasm of the biliary tract. Evolving immunotherapy has important implications for the treatment of ICC. Novel immune checkpoint inhibitors (ICIs) continue to be identified and have demonstrated clinical efficacy...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2025-12-01
|
| Ráidu: | Annals of Medicine |
| Fáttát: | |
| Liŋkkat: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2584667 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|